Stockscreener 앱 받기
4.12
15.41%
0.55
시간 외 거래:
4.07
-0.05
-1.21%
전일 마감가:
$3.57
열려 있는:
$3.58
하루 거래량:
1.72M
Relative Volume:
2.41
시가총액:
$1.39B
수익:
$563.46M
순이익/손실:
$27.92M
주가수익비율:
42.74
EPS:
0.0964
순현금흐름:
$-146.33M
1주 성능:
+34.64%
1개월 성능:
+11.65%
6개월 성능:
-23.28%
1년 성능:
-54.53%
1일 변동 폭
$3.54
$4.12
1주일 범위
$3.05
$4.12
52주 변동 폭
$2.94
$9.25
Alvotech Stock (ALVO) Company Profile
Compare ALVO vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
4.12 | 1.04B | 563.46M | 27.92M | -146.33M | 0.0964 |
TAK
Takeda Pharmaceutical Co Adr
|
17.10 | 55.69B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.855 | 43.77B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.01 | 36.19B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.28 | 32.25B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
517.71 | 26.29B | 3.17B | 1.29B | 1.01B | 27.09 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Underweight |
| 2025-11-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-10-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-09-23 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-02-14 | 개시 | UBS | Buy |
| 2024-01-29 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-09-21 | 개시 | Barclays | Equal Weight |
| 2022-09-07 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-09-06 | 다운그레이드 | Citigroup | Buy → Sell |
| 2022-07-26 | 개시 | Citigroup | Buy |
모두보기
Alvotech 주식(ALVO)의 최신 뉴스
Alvotech SA (ALVO) Cash Flow - TradingKey
Alvotech SA (ALVO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alvotech Revenue Breakdown – NASDAQ:ALVOW - TradingView
Alvotech (ALVO) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Alvotech (ALVO) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Alvotech (ALVO) Q3 2023 Earnings ReportResults, Call & Slides - TipRanks
Alvotech (ALVO) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Alvotech (ALVO) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Alvotech (ALVO) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Alvotech Revenue Breakdown – NASDAQ:ALVO - TradingView
Alvotech SA (ALVO) Income Statement - TradingKey
TradingKey - TradingKey
ALVO Stock Price, Quote & Chart - ChartMill
Alvotech (ALVO) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Alvotech (NASDAQ:ALVO) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Alvotech SA (ALVO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Alvotech (NASDAQ:ALVO) Slides as Market Concerns Deepen - Kalkine Media
Alvotech (NASDAQ:ALVO) Stock Price Down 7.8%Here's What Happened - MarketBeat
Inspection Findings Highlight Hurdles Facing Alvotech’s Launch Plans - insights.citeline.com
Alvotech files automatic mixed securities shelf - MSN
ALVO Stock Price Prediction 2025-2026 | Alvotech Forecast - 24/7 Wall St.
Novo, Alvotech face continued scrutiny at plants tied to recent FDA rejections - Fierce Pharma
Alvotech (ALVO) Could Be 76% Below Fair Value On New $75 Million Debt Facility - simplywall.st
Alvotech (NASDAQ:ALVO) Shares Down 5.5%Here's What Happened - MarketBeat
Alvotech (ALVO) Barclays 27th Annual Global Healthcare Conference 2025 Summary - Quartr
ETFs Investing in Alvotech Stocks - TradingView
Enterprise value to EBITDA forward of Alvotech – NASDAQ:ALVO - TradingView
Alvotech (ALVO) Q3 2025 earnings summary - Quartr
Price to earnings forward of Alvotech – NASDAQ:ALVO - TradingView
Enterprise value to revenue forward of Alvotech – NASDAQ:ALVO - TradingView
Price to sales forward of Alvotech – NASDAQ:ALVO - TradingView
Price to book forward of Alvotech – NASDAQ:ALVO - TradingView
Enterprise value to EBIT forward of Alvotech – NASDAQ:ALVO - TradingView
Enterprise value to EBIT forward of Alvotech – SWB:Z45 - TradingView
Alvotech Seeks Launch Momentum From Renewed FDA Push - insights.citeline.com
Alvotech(ALVO) Stock Options Chain | Quotes & News - Moomoo
‘Seeing the evolution’: As branded patent cliff looms, biosimilar experts size up US hurdles, opportunities ahead - Fierce Pharma
Alvotech Q1 2026 slides: revenue dips 20%, EBITDA rises on mix shift - Investing.com
Alvotech (ALVO) Secured $240 Million In New Capital, Is The Stock Cheap? - simplywall.st
Alvotech Warrant 2022-open end on Financial Disclosures & SEC Filings - TradingView
Transactions of Managers and Closely Associated Persons - Yahoo Finance UK
Should Alvotech’s Expanded US$240 Million Capital Access Require Action From Alvotech (ALVO) Investors? - simplywall.st
Alvotech (ALVO) Stock May Be Undervalued Following Its $125 Million Offering - Yahoo Finance
Janssen Files BPCIA Complaint Against Alvotech Related To Golimumab Biosimilar - marketscreener.com
Alvotech further strengthens liquidity by securing term loan facility of $75 million - Sahm
Alvotech’s US$240 Million Capital Boost Might Change The Case For Investing In Alvotech (ALVO) - Yahoo Finance
Alvotech Secures Term Loan Facility of $75MM from GoldenTree Asset Management - ABF Journal
Alvotech announced that it has received $175 million in funding - marketscreener.com
Biotech firm Alvotech expands capital access with $75M term loan facility - MSN
Alvotech (NASDAQ: ALVO) adds $75M term loan, lifting new capital access to $240M - Stock Titan
Alvotech Secures Additional $75 Million Term Loan Facility Led By GoldenTree Asset Management - marketscreener.com
Alvotech (ALVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.08%
0.17%
자본화:
|
볼륨(24시간):